XML 70 R57.htm IDEA: XBRL DOCUMENT v3.19.2
Note 13 - Segment Information and Dissaggregated Revenue - Operations by Business Segment (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Sales, net $ 49,977 $ 43,710
Gross Profit 6,222 4,988
Depreciation 288 239
Capital Expenditures 414 300
Total Assets 19,790 14,568
Contract Manufacturing [Member]    
Sales, net 48,442 42,082
Gross Profit 5,780 4,471
Depreciation 286 232
Capital Expenditures 413 286
Total Assets 17,580 12,200
Branded Proprietary Products [Member]    
Sales, net 159 252
Gross Profit 2 42
Depreciation 4
Capital Expenditures 13
Total Assets 427 543
Other Nutraceutical Business [Member]    
Sales, net 1,376 1,376
Gross Profit 440 475
Depreciation 2 3
Capital Expenditures 1 1
Total Assets 1,783 1,825
UNITED STATES    
Sales, net 43,170 37,236
UNITED STATES | Contract Manufacturing [Member]    
Sales, net 41,817 35,803
UNITED STATES | Branded Proprietary Products [Member]    
Sales, net 137 204
UNITED STATES | Other Nutraceutical Business [Member]    
Sales, net 1,216 1,229
Non-US [Member]    
Sales, net 6,807 6,474
Non-US [Member] | Contract Manufacturing [Member]    
Sales, net 6,625 6,279
Non-US [Member] | Branded Proprietary Products [Member]    
Sales, net 22 48
Non-US [Member] | Other Nutraceutical Business [Member]    
Sales, net $ 160 $ 147